- 全部删除
 
您的购物车当前为空
CV-4-26 (Compound 22),一种TEAD的共价抑制剂,通过抑制基于YAP/TEAD的转录活动来降低CTGF和CYR61的表达。此外,CV-4-26能够抑制Huh7和HepG2细胞集落的形成,并诱导细胞周期停滞与细胞凋亡(apoptosis)。对于肝细胞癌(HCC)和肝母细胞瘤(HB),CV-4-26展现出了显著的抗肿瘤活性。
CV-4-26 (Compound 22),一种TEAD的共价抑制剂,通过抑制基于YAP/TEAD的转录活动来降低CTGF和CYR61的表达。此外,CV-4-26能够抑制Huh7和HepG2细胞集落的形成,并诱导细胞周期停滞与细胞凋亡(apoptosis)。对于肝细胞癌(HCC)和肝母细胞瘤(HB),CV-4-26展现出了显著的抗肿瘤活性。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 10 mg |  待询   | 待询 | |
| 50 mg |  待询   | 待询 | 
CV-4-26 相关产品
| 产品描述 | CV-4-26 (Compound 22) acts as a covalent inhibitor of TEAD. By inhibiting YAP/TEAD-driven transcription, it diminishes the expression of CTGF and CYR61. Furthermore, CV-4-26 impedes colony formation in Huh7 and HepG2 cells, inducing cell cycle arrest and apoptosis (apoptosis). This compound demonstrates anti-tumoral activity against hepatocellular carcinoma (HCC) and hepatoblastoma (HB).  | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
评论内容